S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Perceptive Advisors/Q4 2024

Perceptive Advisors

Period: Q4 2024 Β· Filed: 2025-02-14
View on SEC EDGAR β†—
AUM
$3.63B
Total portfolio value
Positions
99
Reported securities
Top Holding
VRNA
8.2% $296.9M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2025-02-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
VRNAVERONA PHARMA PLC$296.9M8.18%β€”β€”
8.2%
ACLXARCELLX INC$266.8M7.35%$76.69β€”
7.3%
FOLDAMICUS THERAPEUTICS INC$228.4M6.29%β€”β€”
6.3%
RYTMRHYTHM PHARMACEUTICALS INC$206.0M5.68%$55.98$114.17+104.0%
5.7%
NUVLNUVALENT INC$205.1M5.65%$78.28$123.73+58.1%
5.7%
IOVAIOVANCE BIOTHERAPEUTICS INC$163.6M4.51%$7.40$4.31-41.8%
4.5%
PCVXVAXCYTE INC$140.7M3.88%$81.86$58.39-28.7%
3.9%
ITCIINTRA-CELLULAR THERAPIES INC$107.6M2.97%β€”β€”
3.0%
CNTACENTESSA PHARMACEUTICALS PLC$106.3M2.93%$16.75$40.50+141.8%
2.9%
PRAXPRAXIS PRECISION MEDICINES I$102.3M2.82%$76.96$318.52+313.9%
2.8%
AORTARTIVION INC$79.9M2.20%$28.59$23.97-16.2%
2.2%
MGTXMEIRAGTX HLDGS PLC$76.6M2.11%$6.09$13.92+128.6%
2.1%
EWTXEDGEWISE THERAPEUTICS INC$71.7M1.98%$26.70$39.56+48.2%
2.0%
SLNOSOLENO THERAPEUTICS INC$67.5M1.86%$44.95β€”
1.9%
IMTXIMMATICS N.V$66.7M1.84%$7.11$9.95+39.9%
1.8%
PODDINSULET CORP$60.6M1.67%$261.07$164.48-37.0%
1.7%
SYRESPYRE THERAPEUTICS INC$59.9M1.65%$23.28$86.63+272.1%
1.6%
ATXSASTRIA THERAPEUTICS INC$58.0M1.60%β€”β€”
1.6%
EOLSEVOLUS INC$56.8M1.57%$11.04$6.90-37.5%
1.6%
AXSMAXSOME THERAPEUTICS INC$56.2M1.55%$84.61$244.31+188.8%
1.6%
CRGXCARGO THERAPEUTICS INC$53.1M1.46%β€”β€”
1.5%
IMVTIMMUNOVANT INC$53.0M1.46%$24.77$38.79+56.6%
1.5%
PTGXPROTAGONIST THERAPEUTICS INC$49.1M1.35%$38.60$131.62+241.0%
1.4%
APGEAPOGEE THERAPEUTICS INC$47.4M1.31%$45.30$132.91+193.4%
1.3%
ALDXALDEYRA THERAPEUTICS INC$46.3M1.28%$4.99$2.27-54.5%
1.3%
JANXJANUX THERAPEUTICS INC$43.8M1.21%$53.54$15.54-71.0%
1.2%
ARGXARGENX SE$41.5M1.14%$615.00$939.68+52.8%
1.1%
VKTXVIKING THERAPEUTICS INC$40.1M1.10%$40.24$37.44-7.0%
1.1%
PRAXCALLPRAXIS PRECISION MEDICINES I$38.5M1.06%$76.96$318.52+313.9%
1.1%
AKROAKERO THERAPEUTICS INC$33.0M0.91%β€”β€”
0.9%

Quarter-on-Quarter Activity

Q4 2024 vs. Q3 2024

New Positions (8)

TickerIssuerNotionalSince Filing
JANXJANUX THERAPEUTICS INC$43.8M-71.0%
IKTINHIBIKASE THERAPEUTICS INC$19.3M
PENPENUMBRA INC$17.4M
SEPNSEPTERNA INC$17.2M
DRUGBRIGHT MINDS BIOSCIENCES INC$14.5M
AVRANTERIS TECHNOLOGIES GLOBAL$11.9M
EWEDWARDS LIFESCIENCES CORP$10.7M
RAPTRAPT THERAPEUTICS INC$9.3M

Exited Positions (8)

TickerIssuerNotional
BHVNBIOHAVEN LTD$74.2M
XBISPDR SER TR$39.5M
TILINSTIL BIO INC$23.3M
LIVNLIVANOVA PLC$22.5M
SWTXSPRINGWORKS THERAPEUTICS INC$22.2M
MDTMEDTRONIC PLC$22.1M
IRONDISC MEDICINE INC$19.0M
ICLRICON PLC$12.7M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
VRNAVERONA PHARMA PLC$289.7M+2456.8%
VRNAVERONA PHARMA PLC$289.7M+2456.8%
AMLXAMYLYX PHARMACEUTICALS INC$18.7M+218.7%
IRTCIRHYTHM TECHNOLOGIES INC$4.2M+188.4%
PODDINSULET CORP$27.5M+63.3%-37.0%
EYPTEYEPOINT PHARMACEUTICALS INC$3.2M+48.2%
MREOMEREO BIOPHARMA GROUP PLC$0.5M+33.1%
IMTXIMMATICS N.V$-25.6M+16.0%+39.9%

Trimmed (8)

TickerIssuerNotionalShares Ξ”
APLTAPPLIED THERAPEUTICS INC$-67.3M-89.3%
TARSTARSUS PHARMACEUTICALS INC$-32.3M-85.6%
FULCFULCRUM THERAPEUTICS INC$-4.2M-84.1%
CRNXCRINETICS PHARMACEUTICALS IN$-27.6M-74.5%
OCULOCULAR THERAPEUTIX INC$-19.7M-67.6%
PYXSPYXIS ONCOLOGY INC$-1.6M-62.9%
RCKTROCKET PHARMACEUTICALS INC$-12.4M-59.4%
RAPPRAPPORT THERAPEUTICS INC$-9.8M-58.4%
← Back to Hedge Funds